Development of potential CDK9 inhibitors through pharmacophore-based virtual screening, 3D-QSAR, molecular docking, MD simulation, and in vitro anticancer evaluation
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
No abstract available